CLPT — Clearpoint Neuro Share News
0.000.00%
Last trade - 00:00- $294.06m
- $314.93m
- $36.97m
Brief: Clearpoint Neuro Announces FDA Clearance For Software Version 2.1
Clearpoint Neuro Inc reports results for the quarter ended in June - Earnings Summary
Brief: Clearpoint Neuro Reports Qtrly Loss Per Share $0.18
Brief: ClearPoint Neuro Appoints Mary McNamara-Cullinane As Vice President Of Regulatory Affairs
Clearpoint Neuro Inc reports results for the quarter ended in March - Earnings Summary
Brief: ClearPoint Neuro Reports Q1 Revenue Rose 25% To $5.0 Million
Clearpoint Neuro Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Clearpoint Neuro And Higgs Boson Health Announce Collaboration
Brief: Clearpoint Neuro Announces FDA Clearance Of The Smartframe Array™ Version 1.1
Brief: Clearpoint Neuro Expands Software License And Research Agreement With Philips
Clearpoint Neuro Inc reports results for the quarter ended in December - Earnings Summary
Brief: Clearpoint Neuro Reports Fourth Quarter And Full-Year 2021 Results
Clearpoint Neuro Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: ClearPoint Neuro Reports Fourth Quarter And Full Year 2021 Preliminary Revenue Results And Guidance For Full Year 2022 Revenue
Clearpoint Neuro Inc reports results for the quarter ended in September - Earnings Summary
Brief: ClearPoint Neuro Posts Quarterly Loss Per Share Of $0.18
Brief: Clearpoint Neuro Says Linda M. Liau Joins Board Of Directors
Brief: ClearPoint Neuro Increases Size Of Board From Seven To Eight Members
Brief: Clearpoint Neuro Posts Quarterly Loss Per Share Of $0.17